Nubeqa and Breathing difficulty - a phase IV clinical study of FDA data

Summary:

We study 895 people who have side effects when taking Nubeqa. Breathing difficulty is found, especially among people who are male, 60+ old, have been taking the drug for 1 - 6 months, also take Eliquis and have Prostate cancer.

The phase IV clinical study analyzes which people take Nubeqa and have Breathing difficulty. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 29, 2023

895 people reported to have side effects when taking Nubeqa.
Among them, 25 people (2.79%) have Breathing difficulty.

What is Nubeqa?

Nubeqa has active ingredients of darolutamide. Currently, eHealthMe is studying from 898 Nubeqa users.

What is Breathing difficulty?

Breathing difficulty is found to be associated with 4,888 drugs and 6,009 conditions by eHealthMe. Currently, we are studying 629,579 people who have Breathing difficulty.

Number of Nubeqa and Breathing difficulty reports submitted per year:

Could Nubeqa cause Breathing difficulty?

* Approximation only. Some reports may have incomplete information.

Do you take Nubeqa and have Breathing difficulty?

Check whether Breathing difficulty is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Nubeqa side effects by duration, gender and age:

Nubeqa side effects (898 reports)

Breathing difficulty treatments and more:

Breathing difficulty (629,579 reports)

Common drugs associated with Breathing difficulty:

All the drugs that are associated with Breathing difficulty:

Breathing difficulty (4,888 drugs)

Common conditions associated with Breathing difficulty:

Asthma: 46,342 reports
Primary pulmonary hypertension: 37,578 reports
High blood pressure: 28,171 reports
Rheumatoid arthritis: 27,851 reports
Chronic obstructive pulmonary disease: 26,036 reports

All the conditions that are associated with Breathing difficulty:

Breathing difficulty (6,009 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on darolutamide (the active ingredients of Nubeqa) and Nubeqa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.